| 000 | 01544 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513220627.0 | ||
| 264 | 0 | _c20001107 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/s0306-4522(00)00241-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheer, J F | |
| 245 | 0 | 0 |
_aLack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. _h[electronic resource] |
| 260 |
_bNeuroscience _c2000 |
||
| 300 |
_a661-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBicuculline _xpharmacology |
| 650 | 0 | 4 |
_aCannabinoids _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aDronabinol _xanalogs & derivatives |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 |
_aGABA Antagonists _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterneurons _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReward |
| 650 | 0 | 4 | _aRimonabant |
| 650 | 0 | 4 |
_aVentral Tegmental Area _xcytology |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xphysiology |
| 700 | 1 | _aMarsden, C A | |
| 700 | 1 | _aKendall, D A | |
| 700 | 1 | _aMason, R | |
| 773 | 0 |
_tNeuroscience _gvol. 99 _gno. 4 _gp. 661-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(00)00241-4 _zAvailable from publisher's website |
| 999 |
_c10921769 _d10921769 |
||